- Differences in the Prognosis according to the Periods of Diagnosis in Ulcerative Colitis
-
Chae HB, Jung YS, Park DI, Lee CK, Huh KC, Shin JE, Kim JH, Kim YS, Jung Y, Jung SA, Song HJ, Jang HJ, Hong SN, Kim YH
- KMID: 2164419
- Korean J Gastroenterol.
- 2014 Aug;64(2):93-97.
- doi: 10.4166/kjg.2014.64.2.93
BACKGROUND/AIMS: Infliximab was approved for the treatment of ulcerative colitis (UC) in 2006 and has recently been used as rescue therapy in steroid-refractory UC. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
